DEPENDABLE COMPUTING - FROM CONCEPTS TO DESIGN DIVERSITY

doi:10.1109/PROC.1986.13527

1986-01-01

PRE

AVIZIENIS, A *

LAPRIE, JC

DOI：10.1109/PROC.1986.13527

原文链接

原文求助

摘要

AI总结

对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Proceedings of the IEEE

IF:

25.9

论文数:

9.9K

被引数:

4.5W

机构

暂无机构信息

引用论文

FAULT-TOLERANCE - SURVIVAL ATTRIBUTE OF DIGITAL SYSTEMS

PROCEEDINGS OF THE IEEE

IF25.9

1978-01-01

PREAI

AVIZIENIS, A

Wavelength independence of phosphorescence yields in tris(ethylenediamine)chromium(3+)

Inorganic Chemistry

IF0

2002-05-01

PREAI

A. D. Kirk; C. Namasivayam

Chiral synthesis of Z-2-butylidenecyclohexan-1-OL and -1-YL phenylsulphide from optically active phosphine oxides

Tetrahedron Letters

IF0

1990-01-01

PREAI

Nicholas J.S. Harmat; Smart Warren

The Condensation Products of Aldehydes and Aldol-sensitive β-Dicarbonyl Compounds^1a

The Journal of Organic Chemistry

IF0

2002-05-01

PREAI

B. D. Wilson

Synthesis of Biologically Active Guaianolides with a trans‐Annulated Lactone Moiety

European Journal of Organic Chemistry

IF0

2008-04-22

PREAI

Andreas Schall; Oliver Reiser

Chemistry of 1-iodopropane on copper(110): formation, bonding, and reactions of adsorbed propyl groups

Journal of the American Chemical Society

IF0

2002-05-01

PREAI

Cynthia J. Jenks; Brian E. Bent; Neal Bernstein; Francisco Zaera

Characterization of Chemically Amplified Resists with "Acid Amplifier" for 193 nm Lithography.

Journal of Photopolymer Science and Technology

IF0

1997-01-01

OAAI

Takeshi Ohfuji; Makoto Takahashi; Masaru Sasago; Soh Noguchi; Kunihiro Ichimura

DEAE-Dextran Enhances the Lentiviral Transduction of Primary Human Mesenchymal Stromal Cells from All Major Tissue Sources Without Affecting Their Proliferation and Phenotype

Molecular Biotechnology

IF0

2022-08-23

OAAI

Francesco Amadeo; Vivien Hanson; Patricia Murray; Arthur Taylor

FAULT-TOLERANT DESIGN OF LOCAL ESS PROCESSORS

PROCEEDINGS OF THE IEEE

IF25.9

1978-01-01

PREAI

TOY, WN

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101

Journal of Clinical Oncology

IF0

2010-10-10

OAAI

Thomas S. Lin; Kathleen A. Donohue; John C. Byrd; Margaret S. Lucas; Eva E. Hoke; Elizabeth M. Bengtson; Kanti R. Rai; James N. Atkins; Brian K. Link; Richard A. Larson

查看更多内容